Clinical Evaluation of the NeuMoDx SARS-CoV-2 Assay (COVID-19)

Clinical trial NCT06360757 · TERMINATED

Trial details

NCT number: NCT06360757
Sponsor: QIAGEN Gaithersburg, Inc
Status: TERMINATED
Study type: OBSERVATIONAL

SARS-CoV-2 Acute Respiratory Disease

Start date: 2024-02-06
Primary completion: 2024-07-24
Enrollment: 503

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.